Save your place

Sign in to WhoBought

Please try again later.

Tango Therapeutics, Inc. (TNGX) institutional ownership

Latest close $29.02 Jul 21, 2026
Market cap$708M 52-week range SectorHealthcare
Funds holding · Q1 2026
202
reported TNGX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
116 buyers · 86 sellers

Tango Therapeutics, Inc. (TNGX) price and institutional activity

Dates

Q1 2026

$0 bought by 116 investors
Rtw Investments, LPFMR LLC +114 more
$0 sold by 86 investors
Farallon Capital Management LLCSuvretta Capital Management, LLC +84 more
Bought Sold Totals per quarter; hover a bar for the names.

Tango Therapeutics, Inc. (TNGX) institutional activity · 202

Investor Type Est. change Change Δ Own Date
Rtw Investments, LP · Added
Change +11.8M Date Q1 2026
Rtw Investments, LP Added· Q1 2026 +11.8M Q1 2026
FMR LLC · Added
Change +7.0M Δ Own +245.4% Date Q1 2026
FMR LLC Added· Q1 2026 +7.0M +245.4% Q1 2026
Paradigm Biocapital Advisors LP · New
Change +4.0M Date Q1 2026
Paradigm Biocapital Advisors LP New· Q1 2026 +4.0M Q1 2026
Farallon Capital Management LLC · Reduced
Change −4.0M Δ Own −30.3% Date Q1 2026
Farallon Capital Management LLC Reduced· Q1 2026 −4.0M −30.3% Q1 2026
Holocene Advisors, LP · New
Change +3.9M Date Q1 2026
Holocene Advisors, LP New· Q1 2026 +3.9M Q1 2026
Suvretta Capital Management, LLC · Exited
Change −2.7M Δ Own −100.0% Date Q1 2026
Suvretta Capital Management, LLC Exited· Q1 2026 −2.7M −100.0% Q1 2026
Siren, L.L.C. · Reduced
Change −2.5M Date Q1 2026
Siren, L.L.C. Reduced· Q1 2026 −2.5M Q1 2026
Nantahala Capital Management, LLC · Reduced
Change −2.3M Date Q1 2026
Nantahala Capital Management, LLC Reduced· Q1 2026 −2.3M Q1 2026
Tcg Crossover Management, LLC · Reduced
Change −2.2M Date Q1 2026
Tcg Crossover Management, LLC Reduced· Q1 2026 −2.2M Q1 2026
Adage Capital Partners Gp, L.L.C. · Added
Change +2.2M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Added· Q1 2026 +2.2M Q1 2026
Woodline Partners LP · Reduced
Change −2.1M Date Q1 2026
Woodline Partners LP Reduced· Q1 2026 −2.1M Q1 2026
State Street · Reduced
Change −1.6M Date Q1 2026
State Street Reduced· Q1 2026 −1.6M Q1 2026
Bellevue Group AG · Reduced
Change −1.5M Date Q1 2026
Bellevue Group AG Reduced· Q1 2026 −1.5M Q1 2026
Trv Gp Iv, LLC · Reduced
Change −1.5M Date Q1 2026
Trv Gp Iv, LLC Reduced· Q1 2026 −1.5M Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −1.5M Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −1.5M Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 202

Famous investor activity in Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. (TNGX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Crystal Adam · Officer 2 operations −$799K
Price $29.34–$30.25 Qty −27K Owned 116K ΔOwn −18.9% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Crystal Adam Officer 2 operations $29.34–$30.25 −27K −$799K 116K −18.9% Jul 1, 2026 Jul 2, 2026
Crystal Adam · Officer 2 operations 0
Price $5.20 Owned 314K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Crystal Adam Officer 2 operations $5.20 0 314K Jul 1, 2026 Jul 2, 2026
Azelby Robert · Director 2 operations 42K
Owned 36K Trade date Jun 19, 2026 Filed date Jun 23, 2026
Azelby Robert Director 2 operations 42K 36K Jun 19, 2026 Jun 23, 2026
Ketchum John B. · Director 2 operations 29K
Owned 25K Trade date Jun 5, 2026 Filed date Jun 8, 2026
Ketchum John B. Director 2 operations 29K 25K Jun 5, 2026 Jun 8, 2026
Calhoun Lesley Ann · Director 2 operations 29K
Owned 25K Trade date Jun 5, 2026 Filed date Jun 8, 2026
Calhoun Lesley Ann Director 2 operations 29K 25K Jun 5, 2026 Jun 8, 2026
Rothenberg Mace · Director 2 operations 29K
Owned 25K Trade date Jun 5, 2026 Filed date Jun 8, 2026
Rothenberg Mace Director 2 operations 29K 25K Jun 5, 2026 Jun 8, 2026
Lee Sung · Director 2 operations 4K
Owned 4K Trade date Jun 5, 2026 Filed date Jun 8, 2026
Lee Sung Director 2 operations 4K 4K Jun 5, 2026 Jun 8, 2026
Crystal Adam · Officer 2 operations −$618K
Price $22.25–$23.06 Qty −27K Owned 116K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Crystal Adam Officer 2 operations $22.25–$23.06 −27K −$618K 116K Jun 1, 2026 Jun 3, 2026
Crystal Adam · Officer 2 operations 0
Price $5.20 Owned 341K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Crystal Adam Officer 2 operations $5.20 0 341K Jun 1, 2026 Jun 3, 2026
Crystal Adam · Officer 2 operations −$573K
Price $21.19–$22.00 Qty −27K Owned 116K Trade date May 1, 2026 Filed date May 5, 2026
Crystal Adam Officer 2 operations $21.19–$22.00 −27K −$573K 116K May 1, 2026 May 5, 2026
Crystal Adam · Officer 2 operations 0
Price $5.20 Owned 368K Trade date May 1, 2026 Filed date May 5, 2026
Crystal Adam Officer 2 operations $5.20 0 368K May 1, 2026 May 5, 2026
Gall Matthew · CFO 2 operations 280K
Owned 240K Trade date May 1, 2026 Filed date May 5, 2026
Gall Matthew CFO 2 operations 280K 240K May 1, 2026 May 5, 2026
Lee Sung · Director 2 operations 18K
Owned 5K Trade date Apr 29, 2026 Filed date May 1, 2026
Lee Sung Director 2 operations 18K 5K Apr 29, 2026 May 1, 2026
Crystal Adam · Officer Sell −$962K
Price $25.00 Qty −38K Owned 113K Trade date Apr 15, 2026 Filed date Apr 16, 2026
Crystal Adam Officer Sell $25.00 −38K −$962K 113K Apr 15, 2026 Apr 16, 2026
Crystal Adam · Officer 2 operations 0
Price $5.20 Owned 395K Trade date Apr 15, 2026 Filed date Apr 16, 2026
Crystal Adam Officer 2 operations $5.20 0 395K Apr 15, 2026 Apr 16, 2026
15 of 37
15 of 37 Sign in to continue to older insider transactions.

Tango Therapeutics, Inc. (TNGX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Third Rock Ventures Iv, L.P. 17.0M
% of shares outstanding 15.9% Filing date Sep 4, 2024
Third Rock Ventures Iv, L.P. 17.0M 15.9% Sep 4, 2024
Ecor1 Capital, LLC 10.6M
% of shares outstanding 9.9% Filing date Feb 14, 2025
Ecor1 Capital, LLC 10.6M 9.9% Feb 14, 2025
Rtw Investments, LP 13.3M
% of shares outstanding 9.3% Filing date May 15, 2026
Rtw Investments, LP 13.3M 9.3% May 15, 2026
Adage Capital Management, L.P. 12.8M
% of shares outstanding 9.0% Filing date May 13, 2026
Adage Capital Management, L.P. 12.8M 9.0% May 13, 2026
Tcg Crossover Gp Ii, LLC 11.6M
% of shares outstanding 8.1% Filing date May 15, 2026
Tcg Crossover Gp Ii, LLC 11.6M 8.1% May 15, 2026
FMR LLC 9.9M
% of shares outstanding 6.9% Filing date May 6, 2026
FMR LLC 9.9M 6.9% May 6, 2026
Boxer Capital Management, LLC 7.0M
% of shares outstanding 6.5% Filing date Oct 28, 2024
Boxer Capital Management, LLC 7.0M 6.5% Oct 28, 2024
Boxer Capital, LLC 7.0M
% of shares outstanding 6.5% Filing date Oct 15, 2024
Boxer Capital, LLC 7.0M 6.5% Oct 15, 2024
8 of 15

Tango Therapeutics, Inc. (TNGX) ownership FAQ

Who owns TNGX?

202 reporting institutions disclosed TNGX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.